Chief Executive Officer, Mount Sinai Health System

Kenneth L. Davis, MD is the Chief Executive Officer of the Mount Sinai Health System in New York City, one of the nation’s largest integrated health systems, which includes the Icahn School of Medicine at Mount Sinai, eight hospitals, and more than 400 ambulatory sites. He is a leader in the move away from fee-for-service medicine to population health with the aim of keeping more patients healthy and out of the hospital. As a neurobiologist, Dr. Davis conducted pioneering research that led the FDA to approve four of the first five drugs for treating Alzheimer’s disease. In 2002, he was elected to the Institute of Medicine of the National Academy of Sciences. Dr. Davis is one of the most highly cited researchers in the field of brain diseases. His awards include the George H. W. Bush Lifetime of Leadership Award from Yale. In 2014 he was named a trustee of the Aspen Institute.

Chief Diversity Operations Officer, Mount Sinai Hospitals Group

Pamela Y. Abner, MPA, CPXP, is the Vice President and Chief Diversity Operations Officer for the Mount Sinai Hospitals Group. She has more than fourteen years of experience working with industry leaders to establish strategic and innovative programs for diversity, inclusion, and equity. Utilizing research methodologies, creating education curriculum, and applying best practices, she continuously seeks to help organizations identify discriminatory practices and disparities. A certified patient experience professional and unconscious bias educator, she focuses on eliminating barriers to care, employment, and education for underserved and underrepresented groups, and fostering relationships with community partners.

Ms. Abner received her bachelor’s degree from Brown University and master’s degree in Public Administration from Columbia University School of International and Public Affairs. A frequent presenter in national forums, she was named one of the Most Influential Women in Corporate America in 2019 by Savoy Magazine and a Notable Woman in Talent Resources by Crain’s New York Business in 2020.

Director, Mount Sinai Heart
Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai

Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI, is Director of Mount Sinai Heart and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai.

Dr. Bhatt earned his undergraduate degree at the Massachusetts Institute of Technology. He received his MD from Cornell and a Master of Public Health from Harvard. He is working on his Executive MBA from Oxford. He trained at the University of Pennsylvania and Cleveland Clinic. He then served as the Chief of Cardiology at VA Boston Healthcare System. Subsequently, he was Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital, Editor-in-Chief of the Harvard Heart Letter, and Professor of Medicine at Harvard Medical School.

Dr. Bhatt has been listed in Best Doctors in America from 2005 to 2020. He has authored or co-authored more than 1,900 publications and has been listed from 2014 to 2022 by the Web of Science Group as a Highly Cited Researcher, awarded to 0.1 percent of the world’s researchers. He is one of the co-editors of the leading cardiovascular textbook, Braunwald’s Heart Disease. He is Senior Associate Editor for ACC.org and Editor of the Journal of Invasive Cardiology.

Dr. Bhatt serves on the Board of Directors of Bristol Myers Squibb.

System Chair, Emergency Medicine
Professor of Emergency Medicine and Population Health Science and Policy

Brendan G. Carr, MD, MA, MS, is Professor and Chair of Emergency Medicine at the Icahn School of Medicine at Mount Sinai. He is a recognized thought leader, clinician, researcher, and policy expert. His work focuses on developing innovative policy and delivery system solutions to create a more accessible and equitable acute care system. This portfolio includes the full continuum of emergency care from high acuity conditions (trauma, stroke, cardiac arrest) to low acuity conditions (urgent care, telemedicine). His career has focused on integrating emergency care into the broader health care ecosystem, improving access to care in vulnerable urban, rural, and indigenous communities, and strengthening the health system’s role in ensuring national health security.

Dr. Carr completed his residency in emergency medicine and a fellowship in trauma and surgical critical care. He holds master’s degrees in clinical psychology and health policy research. He has been a federally funded researcher for decades, has authored more than 150 peer-reviewed publications, and has advised and supported global nonprofits, the U.S. Department of Health and Human Services, and the World Health Organization. He is a member of the Royal College of Physicians and Surgeons of Glasgow and the National Academy of Medicine.

Vice Chairman, Obstetrics and Gynecology
Director, Reproductive Endocrinology and Infertility
CEO, RMA of New York

Alan B. Copperman, MD, FACOG, is a highly regarded reproductive endocrinologist and a leader in the fields of infertility, fertility preservation, genomics, and personalized medicine.

Dr. Copperman serves as Vice Chairman of Obstetrics and Gynecology and Division Director of Reproductive Endocrinology and Infertility for the Icahn School of Medicine at Mount Sinai. Dr. Copperman also co-founded RMA of New York, and currently serves as Managing Director and CEO.

Over his distinguished career, Dr. Copperman has served as Medical Director of Progyny, a leading fertility benefits company, Chief Medical Officer of Sema4, a patient-centered health intelligence company, and Physician Council Board Member of RESOLVE, the National Infertility Association, the leading patient advocacy organization. Dr. Copperman was named one of Crain’s New York Business 2022 Notable Health Care leaders.

An experienced and respected clinician leveraging research, practicing data-driven medicine, and prioritizing patient-centric care for more than 25 years, Dr. Copperman is renowned for his contributions to patient care and scientific discovery in the field of reproductive medicine.

Medical Director, The Health Center at Hudson Yards
Eric and Sarah Lane Professor of Pulmonary and Critical Care Medicine

Louis R. DePalo, MD, MS, FCCP, is Medical Director of The Health Center at Hudson Yards and Professor of Medicine, Pulmonary, Critical Care, Sleep Medicine, and Infectious Diseases at Mount Sinai Health System. A physician-scientist, DePalo is highly skilled in the implementation of digital technologies in health system settings. He is a fellow of the American College of Chest Physicians and a member of the American College of Physicians, the Society of Critical Care Medicine, and the American Thoracic Society. DePalo is a Stony Wold-Herbert Fund recipient and was co-investigator on an NIH contract for “A Case Control Etiologic Study of Sarcoidosis”. DePalo has held clinical and academic appointments at the Hospital of the University of Pennsylvania, Albert Einstein College of Medicine, and the Icahn School of Medicine at Mount Sinai.

Assistant Professor of Neurology, Neuroscience and Pathology
Director, Fluid Biomarker Research, Deane Center for Cognitive Health

Fanny M. Elahi, MD, PhD, is a physician-scientist and Assistant Professor in the departments of Neurology, Neuroscience, and Pathology, Molecular and Cell-Based Medicine at the Icahn School of Medicine at Mount Sinai. At Mount Sinai, she also serves as Director of Fluid Biomarker Research for the Barbara and Maurice Deane Center for Cognitive Health and is one of the leaders at the Alzheimer’s Disease Research Center. She is jointly appointed at the James J. Peters Department of Veterans Affairs Medical Center.

Dr. Elahi’s work focuses on understanding vascular aging, examining the link between disease of the brain’s small blood vessels and neurodegeneration. She is passionate about translating laboratory discoveries into clinical applications. Her goal is to extend the brain’s longevity and prevent dementia due to neurodegenerative diseases such as Alzheimer’s disease or rare conditions such as CADASIL. By combining molecular techniques with clinical data, her multidisciplinary research program has revealed commonalities across disease indications that stem from abnormalities in the brain’s blood vessels. She also is working to identify new tests that would enable early-stage detection and accelerated diagnostic precision.

Dean, Women’s Health Research
Professor of Obstetrics, Gynecology and Reproductive Sciences

Michal A. Elovitz, MD, is a physician-scientist, mentor, and advocate. She is the inaugural Dean of Women’s Health Research at the Icahn School of Medicine at Mount Sinai. She is also the founding Director of the Women’s Biomedical Research Institute, which is focused on revealing the biology that drives female specific conditions and understanding sex-specific biology that contributes to significant gender health inequities.

Dr. Elovitz has been actively involved in fundamental and translational research for more than 20 years. Her research is or has been funded by the March of Dimes, Burroughs Wellcome Fund, National Institute of Child Health and Development, National Institute for Nursing Research, and the National Institute of Mental Health. Her research program has focused on understanding the mechanisms and consequences of adverse reproductive and pregnancy outcomes both for the pregnancy of interest and for implications for the long-term health of the mother and child. Her research integrating immunology and microbiology into pregnancy health has led to novel discoveries for reproductive health.

She has created several mentoring programs and is active in supporting women in science and medicine. She is also a public advocate for reproductive rights, gender, and racial equity.

Director, BioMedical Engineering and Imaging Institute
Lucy G. Moses Professor of Medical Imaging and Bioengineering

Zahi A. Fayad, PhD is the founding Director of the Biomedical Engineering and Imaging Institute at Mount Sinai and Professor of Diagnostic, Molecular and Interventional Radiology, and Cardiology, at the Icahn School of Medicine at Mount Sinai. His research focuses on the detection and prevention of cardiovascular disease, with many seminal contributions in biomedical imaging and nanomedicine. His recent collaborative work includes studying the effects of psychosocial stress on the brain and the cardiovascular and immune systems; developing technology to produce nanobiologics for immunotherapies for multiple diseases; development of the imaging research warehouse for data science and AI/ML work; and leveraging mobile health and existing and novel wearables to study disease and deploy digital therapies.

Ward-Coleman Professor and Chair, Nash Family Department of Neuroscience
Director, Drug Discovery Institute

Paul J. Kenny, PhD, is the Ward-Coleman Professor and Chair of the Nash Family Department of Neuroscience and the Director of the Drug Discovery Institute at the Icahn School of Medicine at Mount Sinai. He received his PhD in psychopharmacology from King’s College London. He completed his post-doctoral training in neuropharmacology at The Scripps Research Institute in La Jolla, California. Research in Dr. Kenny’s laboratory is focused on the molecular neurobiology of drug addiction, obesity, and schizophrenia. Dr. Kenny is involved in efforts to develop novel small molecule therapeutic agents for the treatment of drug addiction and other psychiatric indications, and he is the co-founder of Eolas Therapeutics, Inc. Dr. Kenny has won numerous awards for his research, including the Jacob P. Waletzky Memorial Award from the Society for Neuroscience and the Tom Connor Distinguished Investigator Award.

System Chair, Department of Medicine
Murray M. Rosenberg Professor of Medicine

Monica Kraft, MD, is an acclaimed physician-scientist who specializes in clinical and translational research in airway disease. In July 2022, she joined the Mount Sinai Health System and Icahn School of Medicine at Mount Sinai as the Murray M. Rosenberg Professor and System Chair of the Department of Medicine.

Dr. Kraft was previously Chair of the Department of Medicine at the University of Arizona College of Medicine – Tucson. She completed her MD degree at the University of California, San Francisco, her residency at Harbor-UCLA Medical Center, and her fellowship at the University of Colorado Health Sciences Center. From 1995 to 2004, Dr. Kraft worked at National Jewish Health before joining Duke University to create and direct the Duke Asthma, Allergy and Airway Center.

In addition to caring for patients with severe asthma and chronic obstructive pulmonary disease (COPD), Dr. Kraft has published in the New England Journal of Medicine, Journal of American Medical Association, The Lancet, and other publications. Her work has been funded by the National Institutes of Health and the American Lung Association for more than 25 years. She is also co-founder and Chief Medical Officer of RaeSedo, which is developing peptidomimetics for therapy of inflammatory lung disease.

Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences

Dolores Malaspina, MD, MS, MSPH, is Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai, where she directs the system-wide Psychosis Program.

Dr. Malaspina was previously Chair of Psychiatry at the NYU Grossman School of Medicine. She trained at Columbia University in psychiatry and epidemiology. Her research focuses on the genetic and environmental underpinnings of human mental illness, ranging from epidemiology studies to the clinical interface.

Dr. Malaspina has authored 350 papers and received numerous awards, including a National Institutes of Health Challenge Grant. She was first to propose and demonstrate that advancing paternal age is a primary determinant of the risk for schizophrenia through de novo mutations. More recently, she showed that hippocampal inflammation in psychosis is linked to vagal hypofunction and the gut-brain axis. Dr. Malaspina is the Vice Chair for Diversity, Equity, and Inclusion in Mount Sinai’s Department of Psychiatry, and she serves on the steering committee for psychiatric diagnoses in the Diagnostic and Statistical Manual for the American Psychiatric Association. For a decade, she hosted “The Psychiatry Show” for Sirius XM radio.

Director, Innovation Strategy and Instructor, Neurosurgery, Mount Sinai Health System
Associate Professor, Vascular Bionics Laboratory, University of Melbourne, Australia

Thomas J. Oxley, MBBS, PhD, BMedSc, FRACP, is a vascular and interventional neurologist and expert in brain computer interfaces. He is Associate Professor and Joint Laboratory Head of the Vascular Bionics Laboratory, University of Melbourne, Australia, and Clinical Instructor in the Department of Neurosurgery, The Mount Sinai Hospital.

Dr. Oxley has performed more than 1,600 endovascular neurosurgical procedures, including cerebral aneurysm coiling and clot retrievals in acute stroke. He has published more than 100 internationally peer-reviewed articles in journals including JAMA Neurology, Nature Biotechnology, Nature Biomedical Engineering, New England Journal of Medicine, and The Lancet.

Dr. Oxley is the founding CEO of Synchron, a brain data transfer company based in Brooklyn, New York, and has raised more than $145 million in private funding and grants. Synchron is developing the leading endovascular implantable brain computer interface, StentrodeTM, a system that aims to provide a treatment for debilitating medical illnesses and enable patients to feel empowered by reconnecting online in ways that can dramatically improve their lives.

In 2022, Dr. Oxley and Synchron commenced an FDA-approved clinical trial on the Stentrode motor neuroprosthesis that is paving the way towards what would be the first FDA marketing approval for an implanted brain computer interface.

Chief of Breast Surgery, Mount Sinai Health System
Director, Dubin Breast Center

Elisa R. Port, MD, FACS, is the Chief of Breast Surgery for Mount Sinai Health System and Director of the Dubin Breast Center. She joined The Mount Sinai Hospital and the Icahn School of Medicine in 2010, and is now a professor of surgery. After receiving her medical degree from Mount Sinai in 1992, Dr. Port was a general surgery resident at Cedars-Sinai Medical Center in Los Angeles. She then joined Memorial Sloan Kettering Cancer Center for a breast cancer surgery research fellowship, and later completed a general surgery residency at Long Island Jewish Medical Center. In 1999, she joined Memorial Sloan Kettering Breast Surgery Service, where she remained until joining Mount Sinai.

Dr. Port performs hundreds of operations each year and is a leading expert in sentinel-node biopsy, nipple sparing mastectomy, and the use of breast MRI. Dr. Port conducts both clinical and basic science research, and her research has been widely published in numerous journals. She is a member of the American Society of Clinical Oncology, the American Society of Breast Diseases, the Society of Surgical Oncology, and is a Fellow of the American College of Surgeons. She is the author of The New Generation Breast Cancer Book (Random House).

Co-Director, Institute for Health Equity Research
Professor of Emergency Medicine and Health Equity Science

Lynne D. Richardson, MD, FACEP, is Mount Sinai Professor of Emergency Medicine and Health Equity Science and founding Co-Director of the Institute for Health Equity Research at the Icahn School of Medicine at Mount Sinai. A practicing emergency physician, she is a nationally recognized expert in health services research who has made highly influential contributions to eliminating health care disparities in both the research and policy arenas.  She is an expert on community engagement and a national thought leader in the ethics of conducting emergency research. She is skilled in the use of clinical and administrative data to investigate issues of access, quality, and equity.

A native of Harlem, New York, Dr. Richardson graduated from the Massachusetts Institute of Technology with bachelor’s degrees in Life Sciences and Management and received her MD from Albert Einstein College of Medicine. Dr. Richardson is a member of the New York City Board of Health, Chair of the Health Services Quality and Effectiveness Study Section, an elected member of the National Academy of Medicine, and serves on the Board on Health Sciences Policy of the National Academies of Sciences, Engineering, and Medicine.

Assistant Professor of Neuroscience, Neurosurgery and Neurology
Director, Human Neurophysiology Laboratory

Ignacio Saez, PhD, is a neuroscientist and Assistant Professor in the departments of Neuroscience, Neurosurgery, and Neurology at the Icahn School of Medicine at Mount Sinai. He holds dual BSc degrees in Clinical Biology and Biochemistry and Genetics, and a PhD in Neuroscience from Baylor College of Medicine. He completed postdoctoral training at Virginia Tech and the University of California, Berkeley. His research focuses on the neural bases of human thought, decisions, and emotions, which he studies by examining electrical and chemical activity from invasive electrodes implanted for clinical treatment in neurosurgical patients, which provide a unique opportunity to examine high-quality neural activity from the human brain. Some ongoing projects in his laboratory include the development of machine learning models to predict economic decisions from neural activity alone, studying of the neural basis of social behavior, and the development of novel neurostimulation paradigms for treatment of mood disorders such as depression.

Chief Medical Officer, Tisch Cancer Hospital
Chief Quality Officer, Tisch Cancer Center

Cardinale B. Smith, MD, PhD, is a Professor in the Division of Hematology & Medical Oncology and the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai. She is also Chief Medical Officer at the Tisch Cancer Hospital, and Vice President, Cancer Clinical Services and Chief Quality Officer for Tisch Cancer Center, Mount Sinai Health System. She is a medical oncologist and palliative care physician whose clinical practice is focused on lung cancer and palliative care. Her research interests focus on doctor-patient communication, evaluating treatment disparities in cancer care, determinants of cancer patients’ quality of care, characterizing barriers to optimal cancer and palliative care, and developing approaches to eliminating those barriers among racial and ethnic minorities.

Dr. Smith is the Principal Investigator on a National Cancer Institute study to evaluate the role of implicit bias among oncologists on minority cancer patient outcomes. She also shares the responsibility for a National Institute on Minority Health and Health Disparities study to investigate the role of patient beliefs, stigma, medical mistrust, and physicians’ implicit bias on racial disparities in lung cancer screening. Dr. Smith has had numerous publications in peer-reviewed journals.

Director, Mount Sinai Faculty Practice Associates, Primary Care Program
Associate Professor of Medicine, Icahn School of Medicine at Mount Sinai